Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis

Staal, 1977, Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma, Proc. Natl. Acad. Sci. U.S.A., 74, 3065, 10.1073/pnas.74.7.3065

Bellacosa, 1991, A retroviral oncogene, akt, encoding a serine/threonine kinase containing an SH2-like region, Science, 254, 274, 10.1126/science.1833819

Jones, 1991, Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily, Proc. Natl. Acad. Sci. U.S.A., 88, 4171, 10.1073/pnas.88.10.4171

Coffer, 1991, Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families, Eur. J. Biochem., 201, 475, 10.1111/j.1432-1033.1991.tb16305.x

Franke, 1995, The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase, Cell, 81, 727, 10.1016/0092-8674(95)90534-0

Burgering, 1995, Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction, Nature, 376, 599, 10.1038/376599a0

Dudek, 1997, Regulation of neuronal survival by the serine-threonine protein kinase Akt, Science, 275, 661, 10.1126/science.275.5300.661

Kennedy, 1997, The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal, Genes Develop., 11, 701, 10.1101/gad.11.6.701

Bhaskar, 2007, The two TORCs and Akt, Dev. Cell, 12, 487, 10.1016/j.devcel.2007.03.020

Parsons, 2004, Human cancer, PTEN and the PI-3 kinase pathway, Semin. Cell. Dev. Biol., 15, 171, 10.1016/j.semcdb.2003.12.021

Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a

Engelman, 2006, The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism, Nat. Rev. Genet., 7, 606, 10.1038/nrg1879

Gottlob, 2001, Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase, Genes Dev., 15, 1406, 10.1101/gad.889901

Hahn-Windgassen, 2005, Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity, J. Biol. Chem., 280, 32081, 10.1074/jbc.M502876200

Brugge, 2007, A new mutational AKTivation in the PI3K pathway, Cancer Cell, 12, 104, 10.1016/j.ccr.2007.07.014

Kim, 2006, Cancer’s molecular sweet tooth and the Warburg effect, Cancer Res., 66, 8927, 10.1158/0008-5472.CAN-06-1501

Smith, 2001, The rate-limiting step for tumor [18F]fluoro-2-deoxy-d-glucose (FDG) incorporation, Nucl. Med. Biol., 28, 1, 10.1016/S0969-8051(00)00177-3

Robey, 2006, Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt, Oncogene, 25, 4683, 10.1038/sj.onc.1209595

Pasteur, 1861

Robey, 2005, Mitochondrial hexokinases: guardians of the mitochondria, Cell Cycle, 4, 654, 10.4161/cc.4.5.1678

Warburg, 1930

Warburg O, The Metabolism of Tumours: Investigations from the Kaiser Wilhelm Institute for Biology, Berlin-Dahlen. London: Constable. Preface to the English edition. In: Warburg O, Ed. London: Constable & Co. Ltd.; 1930.

Nogueira, 2008, Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis, Cancer Cell, 14, 458, 10.1016/j.ccr.2008.11.003

Deprez, 1997, Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades, J. Biol. Chem., 272, 17269, 10.1074/jbc.272.28.17269

Zhang, 2006, FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression, J. Biol. Chem., 281, 10105, 10.1074/jbc.M600272200

Brugarolas, 2003, TSC2 regulates VEGF through mTOR-dependent and -independent pathways, Cancer Cell, 4, 147, 10.1016/S1535-6108(03)00187-9

Irwin, 2008, Molecular evolution of the vertebrate hexokinase gene family: identification of a conserved fifth vertebrate hexokinase gene, Comp. Biochem. Physiol. D., 3, 96

Arora, 1988, Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP, J. Biol. Chem., 263, 17422, 10.1016/S0021-9258(19)77853-3

BeltrandelRio, 1992, Interaction of mitochondrially bound rat brain hexokinase with intramitochondrial compartments of ATP generated by oxidative phosphorylation and creatine kinase, Arch. Biochem. Biophys., 299, 116, 10.1016/0003-9861(92)90252-R

Wilson, 1995, Hexokinases, Rev. Physiol. Biochem. Pharmacol., 126, 65, 10.1007/BFb0049776

Pastorino, 2002, Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis, J. Biol. Chem., 277, 7610, 10.1074/jbc.M109950200

Majewski, 2004, Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases, Mol. Cell. Biol., 24, 730, 10.1128/MCB.24.2.730-740.2004

Majewski, 2004, Hexokinase–mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak, Mol. Cell, 16, 819, 10.1016/j.molcel.2004.11.014

Adams, 1989, Further characterization of contact sites from mitochondria of different tissues: topology of peripheral kinases, Biochim. Biophys. Acta, 981, 213, 10.1016/0005-2736(89)90031-X

Grimm, 2007, The permeability transition pore in cell death, Apoptosis, 12, 841, 10.1007/s10495-007-0747-3

Chiara, 2008, Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels, PLoS ONE, 3, e1852, 10.1371/journal.pone.0001852

DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002

Pastorino, 2005, Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity, Cancer Res., 65, 10545, 10.1158/0008-5472.CAN-05-1925

Zhao, 2007, Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1, Mol. Cell. Biol., 27, 4328, 10.1128/MCB.00153-07

Miyamoto, 2008, Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II, Cell Death Differ., 15, 521, 10.1038/sj.cdd.4402285

Aubert-Foucher, 1984, Rabbit heart mitochondrial hexokinase: solubilization and general properties, Arch. Biochem. Biophys., 232, 391, 10.1016/0003-9861(84)90554-X

Rathmell, 2000, In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability, Mol. Cell, 6, 683, 10.1016/S1097-2765(00)00066-6

Vander Heiden, 2001, Growth factors can influence cell growth and survival through effects on glucose metabolism, Mol. Cell. Biol., 21, 5899, 10.1128/MCB.21.17.5899-5912.2001

Maurer, 2006, Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1, Mol. Cell, 21, 749, 10.1016/j.molcel.2006.02.009

Nutt, 2005, Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2, Cell, 123, 89, 10.1016/j.cell.2005.07.032

Lassus, 2002, Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization, Science, 297, 1352, 10.1126/science.1074721

Tinel, 2004, The PIDDosome a protein complex implicated in activation of caspase-2 in response to genotoxic stress, Science, 304, 843, 10.1126/science.1095432

Zhivotovsky, 2005, Caspase-2 function in response to DNA damage, Biochem. Biophys. Res. Commun., 331, 859, 10.1016/j.bbrc.2005.03.191

Tu, 2006, In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis, Nat. Cell. Biol., 8, 72, 10.1038/ncb1340

Robertson, 2002, Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis, J. Biol. Chem., 277, 29803, 10.1074/jbc.M204185200

Guo, 2002, Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria, J. Biol. Chem., 277, 13430, 10.1074/jbc.M108029200

Wagner, 2004, Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway, J. Biol. Chem., 279, 35047, 10.1074/jbc.M400708200

Gao, 2005, Essential roles of the Bcl-2 family of proteins in caspase-2-induced apoptosis, J. Biol. Chem., 280, 38271, 10.1074/jbc.M506488200

Skeen, 2006, Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner, Cancer Cell, 10, 269, 10.1016/j.ccr.2006.08.022

Gingras, 1998, 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway, Genes Dev., 12, 502, 10.1101/gad.12.4.502

Hay, 2004, Upstream and downstream of mTOR, Genes Dev., 18, 1926, 10.1101/gad.1212704

Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell, 115, 577, 10.1016/S0092-8674(03)00929-2

Gwinn, 2008, AMPK phosphorylation of raptor mediates a metabolic checkpoint, Mol. Cell, 30, 214, 10.1016/j.molcel.2008.03.003

Berwick, 2002, The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes, J. Biol. Chem., 277, 33895, 10.1074/jbc.M204681200

Bauer, 2005, ATP citrate lyase is an important component of cell growth and transformation, Oncogene, 24, 6314, 10.1038/sj.onc.1208773

Tonks, 2006, Protein tyrosine phosphatases: from genes, to function, to disease, Nat. Rev. Mol. Cell. Biol., 7, 833, 10.1038/nrm2039

Moreno-Sanchez, 2007, Energy metabolism in tumor cells, FEBS J., 274, 1393, 10.1111/j.1742-4658.2007.05686.x

Gottlieb, 2005, Mitochondrial tumour suppressors: a genetic and biochemical update, Nat. Rev. Cancer, 5, 857, 10.1038/nrc1737

Semenza, 2007, Hypoxia-inducible factor 1 (HIF-1) pathway, Sci. STKE, 2007, cm8, 10.1126/stke.4072007cm8

Kaelin, 2002, Molecular basis of the VHL hereditary cancer syndrome, Nat. Rev. Cancer, 2, 673, 10.1038/nrc885

Brandon, 2006, Mitochondrial mutations in cancer, Oncogene, 25, 4647, 10.1038/sj.onc.1209607

Ishikawa, 2008, ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis, Science, 320, 661, 10.1126/science.1156906